{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:10:53Z","timestamp":1758636653141,"version":"3.38.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.2515\/therapie\/2011072","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T18:18:04Z","timestamp":1324405084000},"page":"549-552","source":"Crossref","is-referenced-by-count":4,"title":["Naltrexone et traitement substitutif aux opiac\u00e9s"],"prefix":"10.1016","volume":"66","author":[{"given":"Julie","family":"Dupouy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Poutrain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"Commission nationale des stup\u00e9fiants et des psychotropes","key":"10.2515\/therapie\/2011072_bb0005"},{"issue":"3","key":"10.2515\/therapie\/2011072_bb0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.encep.2008.05.005","article-title":"Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature","volume":"35","author":"Laqueille","year":"2009","journal-title":"Encephale"},{"key":"10.2515\/therapie\/2011072_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2296-10-42","article-title":"Prevalence of problem alcohol use among patients attending primary care for methadone treatment","volume":"10","author":"Ryder","year":"2009","journal-title":"BMC Fam Pract"},{"key":"10.2515\/therapie\/2011072_bb0020","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.2515\/therapie\/2011072_bb0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-3565(25)10212-7","article-title":"Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers","volume":"264","author":"Preston","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.2515\/therapie\/2011072_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568026043451573","article-title":"Endogenous opioids and addiction to alcohol and other drugs of abuse","volume":"4","author":"Gianoulakis","year":"2004","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"10.2515\/therapie\/2011072_bb0035","doi-asserted-by":"crossref","first-page":"387.e5","DOI":"10.1016\/j.ajem.2009.07.007","article-title":"First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction","volume":"28","author":"Lemesle","year":"2010","journal-title":"Am J Emerg Med"},{"unstructured":"Commission nationale de pharmacovigilance. Compte rendu de la r\u00e9union du 25 mai 2010. Suivi national de la m\u00e9thadone AP-HP g\u00e9lule et sirop. http:\/\/www.chu-montpellier.fr\/publication\/inter_pub\/R364\/A7151\/commissionPV25-05-10.pdf","key":"10.2515\/therapie\/2011072_bb0040"},{"issue":"7","key":"10.2515\/therapie\/2011072_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pds.892","article-title":"Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database","volume":"13","author":"Pradel","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.2515\/therapie\/2011072_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.1717","article-title":"Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study","volume":"18","author":"Noize","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"unstructured":"Assurance Maladie. M\u00e9dic\u2019AM 2004-2009. http:\/\/www.ameli.fr\/fileadmin\/user_upload\/documents\/MEDICAM_2004-2009.zip","key":"10.2515\/therapie\/2011072_bb0055"},{"unstructured":"Commission d\u2019AMM. S\u00e9ance du 21 juillet 2011. http:\/\/www.afssaps.fr\/content\/download\/34864\/455346\/version\/1\/file\/CP-Commission-AMM-21072011.pdf.","key":"10.2515\/therapie\/2011072_bb0060"},{"unstructured":"Commission d\u2019AMM. S\u00e9ance du 9 juin 2011. http:\/\/www.afssaps.fr\/content\/download\/34072\/446142\/version\/1\/file\/CP-Commission-AMM-90611.pdf","key":"10.2515\/therapie\/2011072_bb0065"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630806X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630806X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T05:40:40Z","timestamp":1742103640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571630806X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S004059571630806X"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2011072","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}